RxDoctor Payments DataLook up a doctor →

Vasili Karas, MD

Adult Reconstructive Orthopaedic Surgery · Chicago, ILNPI 1063778413

Payments from drug & device makers

$531,199in general payments, 2019–2025

Across 401 payments — averaging $1324.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Omnilife Science, Inc$431K
  • Stryker$92K
  • Depuy Synthes Products, Inc.$3K
  • Encore Medical, LP$2K
  • Microport Orthopedics Inc$761
  • Microport Navibot International LLC$415
  • plus $893 from 8 others
$6,000in research payments, 2019–2025

Across 1 payment — averaging $6000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Omnilife Science, Inc$6K

What the payments were for

  • Royalty or licence$134,33951%
  • Consulting fees$99,81838%
  • Speaking & faculty fees$9750%
  • Travel & lodging$14,4505%
  • Food & beverage$14,2245%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$531,199 in reported general payments places this provider in the 85th percentile of 67 adult reconstructive orthopaedic surgery providers in Illinois.

See all adult reconstructive orthopaedic surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$857,835
Medicare patients
1,012
Services billed
18,648

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban15$8,226
Meloxicam330$1,423
Pantoprazole Sodium139$1,306
Ondansetron OdtOndansetron114$1,252
Tramadol Hcl286$1,147
Cefadroxil83$1,093
Oxycodone Hcl170$900
Diclofenac Sodium70$819
Mupirocin117$762
Celecoxib19$635
Amoxicillin360$597
Gabapentin66$492
Pregabalin67$320
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$267
Cyclobenzaprine Hcl14$162

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →